DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Brendan Mcdermid - 1 Mitchell Goldberg - 1 what's - 1 Goldberg - 1
Top related locs:
New York City U.S Washington Big Tech
Top related orgs:
New York Stock Exchange - 1 ClientFirst - 1 Juniper Networks - 1 Nvidia - 1 Devices - 1 Traders - 1 Group - 1

Search resuls for: "Mitchell Goldberg"


4 mentions found


☆ This record-breaking market just keeps going higher and higher. Here's why
  + stars: | 2024-01-19 | by ( Jeff Cox | ) www.cnbc.com   time to read: +3 min
Brendan Mcdermid | ReutersThe stock market keeps scaling new heights as investors focus on the good and ignore the bad, no matter how bad the bad parts might look sometimes. Prospects for a slowing economy, geopolitical unrest and turmoil in Washington aren't scaring market participants largely because none of those threats have turned into much in reality. As it has digested the various headwinds and tail winds, the market is pushing toward a record closing high. Along with commentary from multiple Fed officials, the tight labor market has taken some of the steam of out the market's anticipation for rate cuts this year. Where the market a week ago was nearly certain the Fed would start cutting in March and keep going with six more quarter percentage point moves this year, pricing shifted Friday.
Persons: Brendan Mcdermid, Mitchell Goldberg, what's, Goldberg Organizations: New York Stock Exchange, Reuters, ClientFirst, Juniper Networks, Nvidia, Devices, Traders, Group Locations: New York City, U.S, Washington, Big Tech
☆ Second judge says US not liable in Moderna COVID-19 vaccine patent case
  + stars: | 2023-04-26 | by ( Blake Brittain | Thomson Reuters | Blake Brittain Reports On Intellectual Property Law | ) www.reuters.com   time to read: +2 min
Chief Judge Colm Connolly's ruling for Alnylam Pharmaceuticals Inc (ALNY.O) came just over a month after a different judge in Delaware rejected Moderna's similar motion in another vaccine patent lawsuit. Representatives for Moderna and Alnylam did not immediately respond to requests for comment. Moderna made the same argument in a motion to dismiss part of another patent lawsuit brought by Arbutus Biopharma Corp (ABUS.O) and Genevant Sciences GmbH. U.S. District Judge Mitchell Goldberg rejected Moderna's motion in that case last year and said it had not yet proven the government was more than an "incidental beneficiary" of the shots. Goldberg denied the motion for a second time last month after the federal government backed Moderna's position.
☆ U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit
  + stars: | 2023-02-15 | by ( Blake Brittain | Thomson Reuters | Blake Brittain Reports On Intellectual Property Law | ) www.reuters.com   time to read: +2 min
[1/2] People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/IllustrationFeb 15 (Reuters) - The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc (MRNA.O), the Department of Justice told a Delaware federal court on Tuesday. Moderna made the same argument last year in an unsuccessful bid to win an early dismissal of the lawsuit. Both Moderna and Pfizer Inc (PFE.N) have been the target of multiple patent lawsuits over their COVID vaccines, including a lawsuit brought by Moderna against Pfizer in August. The case is Arbutus Biopharma Corp v. Moderna Inc, U.S. District Court for the District of Delaware, No.
☆ The S&P 500 has fallen to a fresh 2022 low. Here's what investors should do next
  + stars: | 2022-09-28 | by ( Michelle Fox Darla Mercado | Cfp | Michelle Fox | ) www.cnbc.com   time to read: +5 min
Instead, it may be a good time to make adjustments to your portfolio or take some tax losses. For those with a long enough time horizon of five- or 10 years, or more, the sell-off could be an opportunity to buy the right stocks at a discount. Finding shelter For those worried about risk, stability can be found in the Treasury market. You might consider putting some of your holdings in Treasury bills, Treasury notes or Series I savings bonds. You can also get exposure to the Treasury market without owning the actual securities through a mutual fund or exchange-traded fund.
0 next >>
Total: 4